Skip to main content

B. Riley Just Raised D-Wave Quantum's Price Target to $40 — Here's Why It Matters

 


B. Riley Just Raised D-Wave Quantum's Price Target to $40, Here's Why It Matters

The Headline That Caught Wall Street's Attention

Some analyst upgrades feel like background noise. This one doesn't.

When B. Riley Securities bumped its D-Wave Quantum (NYSE: QBTS) price target from $36 to $40 while keeping its Buy rating intact, it wasn't just a $4 adjustment. It was the latest move in a pattern of accelerating conviction that's worth paying attention to.

Here's the thing about Wall Street: analysts don't raise targets in a vacuum. They do it when the story changes. And D-Wave's story has been changing, fast.

As of early June 2026, QBTS trades around $29. That $40 target implies roughly 38% upside from current levels. But the real question isn't whether the stock will hit $40 tomorrow. It's whether D-Wave is building something that justifies that valuation, or whether we're watching another quantum hype cycle inflate.

Let's dig in.


Why B. Riley Keeps Raising the Bar

From $20 to $40: A Timeline of Growing Conviction

If you've been tracking B. Riley's coverage of D-Wave, the trajectory tells its own story:

  • July 2025: Target raised to $22 from $20
  • September 2025: Target lifted to $33 from $22
  • Late 2025/Early 2026: Target moved to $36
  • Now: Target raised again to $40

That's a doubling of the price target in less than a year. In analyst-speak, that's not a tweak, that's a recalibration of the entire investment thesis.

B. Riley isn't alone in this optimism. Cantor Fitzgerald and Roth MKM both maintain $40 targets, while Needham has gone as high as $48. The consensus has been drifting upward, but B. Riley's repeated revisions suggest they're seeing momentum in real-time that earlier models underestimated.

What's Driving the Analyst's Optimism?

A few concrete developments are fueling this:

1. Commercial contracts are materializing. D-Wave isn't just selling a futuristic dream, it's signing deals. The company reportedly secured a $10 million, two-year quantum computing-as-a-service (QCaaS) agreement with a Fortune 100 client. That's recurring revenue, not a one-off research grant.

2. The Quantum Circuits acquisition. D-Wave acquired Quantum Circuits Inc., giving it gate-model quantum capabilities to complement its existing annealing systems. It's the only company offering both, a genuine differentiator.

3. Government tailwinds. The formation of a dedicated U.S. government business unit, combined with the Trump administration's focus on keeping pace with China in quantum development, adds a geopolitical optionality to the investment case.

4. The Florida move. D-Wave announced plans to relocate its headquarters and a major R&D facility to Boca Raton, Florida. While not directly revenue-generating, it signals expansion mindset and potential tax incentives.


D-Wave Quantum by the Numbers: Does $40 Make Sense?

Current Valuation vs. Price Target

Let's be blunt: D-Wave is not a value stock. It's a bet on the future.

At ~$29 per share, QBTS carries a market cap of roughly $10.8 billion. The stock has traded as high as $46.75 and as low as $12.75 over the past 52 weeks, volatility is the name of the game.

A $40 target from $29 implies about 38% upside. But here's where it gets interesting: the average analyst target sits around $35-37, so B. Riley's $40 is actually on the bullish end of the consensus. It's not wild, it's optimistic but grounded.

The Revenue Story (Or Lack Thereof)

This is where skepticism is healthy. D-Wave's trailing twelve-month revenue is approximately $12.4 million. Against an $11 billion market cap, that's a price-to-sales ratio north of 800.

Let that sink in.

You're not paying for what D-Wave is today. You're paying for what it could become if quantum computing transitions from experimental to essential. That's a massive "if," and it's why position sizing matters enormously here.

Cash Position and Burn Rate

The company holds about $588 million in cash, which provides a runway. But it's still burning cash, levered free cash flow is negative, and the company posted a net loss of roughly $368 million over the trailing year. The $330 million shelf registration filed earlier also creates potential dilution risk if D-Wave raises more capital.

So does $40 make sense? Only if you believe the revenue inflection point is closer than the bears think.


What Is Quantum Annealing, and Why Does It Matter?

The Elevator Pitch (With a Metaphor)

Imagine you're trying to find the lowest point in a mountain range. A classical computer is like a hiker who walks downhill from wherever they start. They might find a valley, but miss the deepest one hidden behind a ridge.

Quantum annealing is like having the ability to tunnel straight through the mountain. It explores all possible paths simultaneously, making it uniquely suited for optimization problems, logistics, drug discovery, financial modeling, AI training.

D-Wave's Advantage2 system, with over 4,400 qubits, is the most powerful annealing quantum computer the company has built. It's not a general-purpose machine (that's gate-model quantum computing), but for specific problem sets, it's genuinely useful today — not ten years from now.

D-Wave's Dual-Platform Edge

Here's what separates D-Wave from IonQ, Rigetti, and other quantum pure-plays: they're the only company commercially offering both annealing and gate-model systems. That dual-platform strategy means they can serve different customer needs without betting the farm on a single technological path.

It's like being both a diesel and electric engine manufacturer while the rest of the industry is picking sides.


D-Wave vs. IonQ vs. Rigetti

IonQ trades at a premium and has partnerships with AWS and Azure. Rigetti is smaller and more volatile. D-Wave sits in the middle, established enough to have real customers, small enough to still be a high-growth story.

B. Riley's preference for D-Wave likely stems from that commercial traction. While IonQ is promising, D-Wave is already generating revenue from actual deployments. In a sector full of PowerPoint promises, "we have paying customers" is a powerful differentiator.


Risks Every Investor Should Consider

The Valuation Reality Check

Let's not romanticize this. A price-to-sales ratio of 800+ means the market has already priced in years of exponential growth. If D-Wave stumbles on execution, misses a contract, or faces technical delays, the downside is severe.

This is a stock that can drop 30% in a week on bad news. It has before.

Dilution and Shelf Registration

D-Wave filed a $330 million shelf registration, giving it the option to issue new shares. That's smart treasury management, but it means existing shareholders could see their ownership diluted. If you're buying QBTS, you're implicitly trusting management to deploy that capital wisely.

The Quantum Hype Cycle

We've been here before. AI, blockchain, 3D printing, all went through phases where the narrative outran the fundamentals. Quantum computing is real, but the timeline to widespread commercial adoption is uncertain. D-Wave could be a pioneer, or it could be a cautionary tale.

The honest truth? No one knows for sure. That's what makes it speculative.


What Should Investors Do Now?

For Existing Shareholders

If you're already holding QBTS, B. Riley's upgrade is validation, but not a reason to double down blindly. Consider trimming on spikes and letting your winners run with a trailing stop. The trend is your friend until it isn't.

For Potential Buyers

Don't chase. At $29, you're getting a better entry than at $46, but you're still buying a story, not a cash flow. If you believe in quantum computing's commercialization over the next 3-5 years, a small position makes sense. If you need steady income or can't stomach 50% drawdowns, this isn't your stock.

Position Sizing in Speculative Tech

Here's a rule of thumb I like: speculative positions should never keep you awake at night. If a 100% loss in QBTS would damage your financial plan, you're too concentrated. Treat it like a venture capital bet, high upside, high probability of total loss, sized accordingly.



B. Riley's move to $40 isn't just about the number. It's about a narrative shift: D-Wave Quantum is transitioning from "interesting science project" to "potentially viable commercial enterprise." The contracts are real, the technology is differentiated, and the analyst community is warming up.

But, and this is crucial, the valuation has already run ahead of the fundamentals. The $40 target assumes D-Wave continues executing at a high level, commercial adoption accelerates, and the capital markets remain friendly. That's a lot of assumptions.

For investors with the risk tolerance and time horizon, QBTS remains one of the most interesting bets in quantum computing. Just don't bet the farm. Bet what you can afford to lose, and enjoy watching the future unfold.


Popular posts from this blog

Silicon Valley Is Bracing for a Permanent Underclass, Should You Be Worried Too?

  Silicon Valley Is Bracing for a Permanent Underclass, Should You Be Worried Too? There's a joke going around Silicon Valley that stopped being funny about six months ago. It goes like this: if you're not aggressively adopting AI right now, not just using it, but building with it, shipping with it,  becoming  it, you're going to end up in the permanent underclass. Not "struggling a bit." Not "between jobs." Underclass. As in: left behind forever, watching from the outside while a tiny elite of capital-owners and AI-builders run the world without you. The thing about jokes that stop being funny? That's usually when they start being true. I live in San Francisco, the same San Francisco where, as one recent opinion piece put it, "most people I know in the A.I. industry think the median person is screwed, and they have no idea what to do about it." Young researchers pull million-dollar salaries. Startup founders chase the next unicorn. And...

ChatGPT Health: Your AI-Powered Personal Health Assistant Is Here (2026 Guide)

  ChatGPT Health: Your AI-Powered Personal Health Assistant Is Here (2026 Guide) Remember the last time you tried to make sense of your bloodwork results at 11 PM? Or when you were frantically Googling symptoms before a doctor's appointment, trying to sound halfway intelligent when explaining what's been going on? Yeah... we've all been there. Here's the thing that drives most of us crazy about healthcare: your medical information is scattered everywhere. Lab results in one patient portal. Fitness data in your Apple Watch. That food log in MyFitnessPal you swore you'd keep up with (but haven't looked at in three weeks). Insurance information buried in some PDF you downloaded once and can't find anymore. It's exhausting. And honestly? It's a little ridiculous that in 2026, managing your health still feels like piecing together a puzzle where half the pieces are missing and the other half are in different boxes. Enter ChatGPT Health . OpenAI just...

A New Generation of Mall Rats Has Arrived (And They're Running the Place)

A New Generation of Mall Rats Has Arrived (And They're Running the Place) Wait… Didn't We Declare Malls Dead? Remember those articles? The ones with photos of hollowed-out Sears stores and sad, flickering food courts, those bleak "dead mall" YouTube videos that millions of us watched with a weird mix of nostalgia and relief? We were so sure. Malls were done. E-commerce won. Amazon got the trophy. Well. About that. Something quietly, stubbornly strange has been happening over the past couple of years. The parking lots are full again. The sneaker stores have lines. And the teenagers roaming the corridors with boba teas and matching fits? They don't look like people who just wandered in by accident. Visits to indoor malls on Super Saturday, the last Saturday before Christmas 2024, jumped a staggering 177% compared to the year-to-date daily average, according to foot traffic intelligence platform Placer.ai. That's not a blip. That's a comeback ...